Korro Bio, Inc. is an RNA editing company, which engages in the discovery and development of genetic medicines. The company was founded by Nessan Bermingham, Jean-Francois Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
101
Frequently Asked Questions
What is Market Cap of Korro Bio Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Korro Bio Inc. market cap is $310.37M.
What is the 52-week high for Korro Bio Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Korro Bio Inc. 52 week high is $97.91 as of June 28, 2024.
What is the 52-week low for Korro Bio Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Korro Bio Inc. 52 week low is $9.15 as of June 28, 2024.
What is Korro Bio Inc. stock price today?
Korro Bio Inc. stock price today is $33.47.
What was Korro Bio Inc. stock price yesterday?
Korro Bio Inc. stock price yesterday was $33.45.
What is the PE ratio of Korro Bio Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Korro Bio Inc.’s P/E ratio is -0.88.
What is the Price-to-Book ratio of Korro Bio Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Korro Bio Inc. P/B ratio is 1.7740.
What is Korro Bio Inc.'s EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Korro Bio Inc.'s EBITDA is -7.64.
What is the 50-day moving average of Korro Bio Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Korro Bio Inc. 50-day moving average is $50.59.